Among inducers of myeloid differentiation for leukemic cells, tiazofurin is of special interest because its mechanism of action is known; it inhibits inosine monophosphate dehydrogenase and thus decreases the guanine nucleotide pool. Reported here are three aspects of tiazofurin induction of myeloid differentiation in HL60 human acute promyelocytic leukemia cells. First, inductive efficacy was evaluated for analogues ara-tiazofurin, xylo-tiazofurin, and selenazofurin, for dinucleotide anabolites thiazole-4-carboxamide adenine dinucleotide (TAD) and selenazole-4-carboxamide adenine dinucleotide (SAD), and for a phosphodiesterase-resistant HE INTRACELLULAR concentration of guanine nu-T cleotides plays a central role in cellular differentiation in both prokaryotes and eukaryotes.' Differentiation is associated with a reduced concentration of GDP and GTP. For the study of myeloid differentiation, the HL60 acute promyelocytic leukemia cell has been a useful human
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The C-glycosyl thiazole antitumor agent tiazofurin (TF; Fig la) decreases HL60 cell proliferation and induces differentiated characteristics. These characteristics include the ability to phagocytize and reduce nitroblue tetrazolium and the display of differentiation antigens on the cell surface: ' The differentiation-inducing action of T F has also been noted in other human cell lines, including T-lymphoid CEM-2 leukemia: K-562 erythr~leukemia,~ and MCF-7 breast cancer."
Both the antiproliferative and maturation-inducing effects of TF have been related to this agent's ability to reduce intracellular guanine nucleotide pools:~" This reduction results from inhibition of inosine monophosphate dehydrogenase (IMPd), the enzyme catalyzing the ratelimiting step in the de novo synthesis of guanine nucleotides." The major inhibitor of IMPd is an anabolite of TF, thiazole-4-carboxamide adenine dinucleotide (TAD; Fig  lc) .l3,I4 TAD is a more potent IMPd inhibitor than ribavirin 5'monophosphate (RMP), the active anabolite of the antiviral agent ribavirin (RV).L5, 16 Resistance to TF is associated in part with increased degradation of TAD via a phosphodie~terase.'~-~~ The P-methylene analogue of TAD (P-TAD; Fig le) is resistant to this phosphodiesterase. This resistance is presumed to be the basis for p-TAD'S cytotoxicity for TF-resistant cells? ' Other analogues of TF have been studied. Ara-and xylo-TF (Fig If and g ) show no cytotoxicity"; however, the selenium analogue of TF, selenazofurin (SF ; Fig lb) , is up to 10-fold more cytotoxic than TF.23-25 SF also induces HL60 cell maturation'," and its corresponding dinucleotide anabolite, selenazole-4-carboxamide adenine dinucleotide ( S A D ; Fig Id) , binds more tightly to IMPd than does
In this study, we have used HMO cells to (1) compare the efficiency with which TF, ara-TF, xylo-TF, SF, SAD, TAD, and P-TAD induce maturation; (2) demonstrate synergism in inductive efficacy between TF and RV, and (3) provide evidence that the FcRIII receptor induced by T F is sensitive to cleavage by phosphatidylinositol-specific phospholi-TAD analogue, p-methylene TAD. The results showed that the parent compounds are more effective inducers than the dinucleotide derivatives and that the selenarole analogues are more effective inducers than the thiazole compounds. Second, HL60 cell induction by tiazofurin was shown to be synergistic with that produced by the antiviral agent ribavirin. Finally, tiazofurin was found to induce expression of a phosphatidylinositol-specific phospholipase C-sensitive Feyreceptor 111 (FcRIII) on HL60 cells, a feature consistent with neutrophilic, but not monocytic, differentiation. 0 1991 by The American Society of Hematology.
pase C, a characteristic of FcRIII expressed by neutrophils rather than monocytes. with and without phosphatidylinositol-specific phospholipase C treatment was performed as described by Levy et a1.= The nitroblue tetrazolium (NBT) reduction test was performed as described by Baehner and Nathan.29
MATERIALS AND METHODS

HMO
Flow cytometry was performed as previously described" on an EPICS V multiparameter flow cytometerlcell sorter (Coulter Electronics) with an argon ion laser (SpectraiPhysics, Mountainview, C A Model 2025) tuned to 488 nm at 500 mW. Fluorescence differentiation because about 2% of cells are positive without treatment; hence, an agent could appear to induce NBT positivity by merely killing NBT-negative cells. Therefore, to equitably compare differentiation-inducing efficiency, the number, rather than the percentage, of NBTpositive cells has been calculated. For any given concentration of a given drug, the percentage of positive cells has been multiplied by the total number of cells to yield the number of positive cells, shown in Fig 2C. The optimal concentration is that high enough to effectively induce NBT positivity but not so high as to excessively reduce cell number. The height of the peak at this concentration is a measure of inductive efficacy.
A comparison of the effects of SF, S A D , TF, and TAD in Fig 2C shows that the selenazole compounds are in general more efficient inducers than the thiazole compounds. The most effective concentrations for the selenazole compounds are one-half to one log lower than those for the analogous thiazole compounds. This finding is consistent with the observation that the active anabolite SAD binds to IMPd more tightly than does TAD. The Ki for inhibition of IMPd by SAD with respect to NAD is at least one order of For A comparison of inductivc cfficicncy of SF with SAD and T F with TAD indicatcs that in both cascs thc parcnt compound is a morc cfficicnt induccr than the dinuclcotidc analoguc. This finding may at first appcar inconsistcnt with thc fact that thc dinuclcotidcs bind lMPd with Kis four orders of magnitudc lcss than that of thc parcnt compounds."." Howcvcr, intcrprctation of thcsc data must takc into account thc hydrolytic instability and transport propcrtics of thc dinuclcotidcs. Although TAD (SAD) is as toxic as T F (SF) on a molar basis, it cntcrs thc ccll much lcss rcadily than thc ncutral nuclcosidc.".'" TAD is not cytotoxic to a TF-rcsistant P38X ccll linc that lacks thc pyrophosphorylasc rcquircd to synthcsizc TAD from thc parcnt compound.?"Thus. it is likcly that cxogcnous dinuclcotidc cxcrts its cffcct by hydrolysis of thc phosphodicstcr bond, first to thc monophosphatc and thcn to thc parcnt nuclcosidc. Thc nuclcosidc may thcn bc transportcd acros thc ccll mcmbranc and rc-anaboliscd back to thc activc dinuclcotidc."
In light of thcsc considcrations, results for f3-TAD arc notcworthy. Although f3-TAD and TAD bind to lMPd with cqual affinity, f3-TAD is approximatcly 10-fold lcss cytotoxic than TAD for P388 cclls." f3-TAD docs induce diffcrcntiation in H M cclls, although its pcak induction conccntration is approximatcly 1.5 log highcr than that for T F and almost onc log highcr than that for TAD (Fig 2C) . This observation is consistcnt with thc fact that cxogcnous f3-TAD cannot bc hydrolyzed to T F and must excrt its cffccts by entering the ccll intact." Although transport of f3-TAD is lcs.. cfficicnt than that for thc parcnt nuclcoside, this analoguc has ccrtain advantages. A number of ccll lines havc bccn shown to contain a phosphodicstcrasc that hydrolyzcs TAD ("TADasc")." ?n Onc factor in TF resistance is an incrcasc in TADasc activity. producing an incrcasc in thc ratc of degradation of thc activc dinuclcotidc anabolitc.'" @-TAD lacks TAD'S phosphodicstcr bond (Fig IC and c) and is thus hydrolytically morc stablc." This agcnt has shown cytotoxicity against TF-rcsistant P388 cclls." Thus, f3-TAD may scrvc as an cffcctivc inducing agcnt in TF-rcsistant Icukcmias.
Failure of ara-and xylo-TF to induce diffcrcntiation (Fig  2) is consistcnt with thc lack of cytotoxicity of thcsc compounds in othcr systcms." Rcplaccmcnt of thc ribosc moicty found in T F with the arabinosc and xylose moictics found in ara-and xylo-TF rcsults in significant changes in both conformation and hydrogcn-bonding propcrtics."Thus, cithcr ara-and xylo-TF may not bc anabolizcd to thcir corresponding dinuclcotidcs (ara-TAD and xylo-TAD) or, if anabolizcd. thcsc dinuclcotidcs may not cffcctivcly bind IMPd."
T F inhibits lMPd via its dinuclcotidc anabolite TAD. TAD acts as an NAD analoguc, mimicking nicotinamide binding at thc cofactor sitc.'h.l: " In contrast, RV inhibits lMPd via its anabolite RMP, which appcars to act as a substrate analoguc, binding at thc inosine
The prcscncc of two potential sitcs of inhibitor action suggcstcd the possibil- 
at a fixed concentration of TF and varying concentrations of RV. As shown in Fig 3A, the percentage of NBT-positive cells was higher for the two agents together than the sum of the numbers of NBT-positive cells for each agent alone. In a confirming experiment of similar design, the pairs of concentrations for RV and TF producing 25% to 35% NBT positivity were compared with the concentrations of the two agents needed if their effects had been purely additive. Results are shown in the form of an isobologram in Fig 3B. Results indicate that inductive effects of T F and RV are indeed synergistic.
Little investigation of HL60 surface antigen induction by TF has been reported. Induction of the antigen recognized by OKMl has been observed,' but this antigen is common to granulocytes and monocytes.36 Surface antigen identification has been extensively used to determine the lineage of leukemic cells. 37 We have quantitated surface antigen expression to investigate the lineage of differentiation induced by TF. Following culture with lo-' m o l t TF for 7 days, HL60 cells were analyzed for their ability to bind lineage-specific antibodies. These antibodies include M 0 2 (CD14)% and VIM13 (CD14)3y for monocytes, WEMGlu and Ll2.z4l for granulocytes, and B9.842 and MY7 (CD13)43 for both monocytes and granulocytes. The monocyte-specific and granulocytespecific antigens were not induced. The monocyte-granulocyte antigens were slightly induced.
Of all the antigens assessed, the only one markedly induced in response to TF was that recognized by 3G8." 3G8 recognizes the type I11 receptor for the Fc portion of Ig (FcRIII). As shown in Fig 4A, TF increased has focused on the mechanism of TF-and SF-induced myeloid differentiation. Reduction of the guanosine nucleotide pool by these and other IMPd inhibitors4 appears to compromise the ability of G proteins to function as transducers of intracellular signals.5o In both K562 and L1210 cells, TF and SF decrease diacylglycerol content and protein kinase C a~tivity.~'*~* In W62 cells, T F also resulted in the downregulation of the c-Ki-ras gene before commitment to differentiation.' Genes of the ras family are often mutationally altered in myeloid leukemias.53s54 Clinically, TF has induced complete hematologic remissions in some patients with end-stage acute nonlymphocytic leukemia or in myeloblastic crisis of chronic myeloid leukemia." Thus, T F and related compounds deserve further study as both selective probes of G-protein-mediated mechanisms of myelopoesis and as potentially useful clinical agents. 
